Businesses for Sale and Investment Opportunities

- Company and product: Enbiosis has developed an advanced artificial intelligence algorithm that analyzes the human gut microbiome and recommends personalized food and supplements to individuals to improve their gut health and address chronic disorders such as gastrointestinal disorders, skin-related disorders, and weight loss issues. - How it works: Patients/customers send their stool samples to any NGS laboratory in their region. Enbiosis takes the raw bacterial DNA data to the local server (to avoid data protection risks) and creates a personalized report, which is sent to patients and, if required, their practitioners within minutes. - Business model: Enbiosis's microbiome test can be sold through practitioners and/or directly to customers, depending on market dynamics. Practitioners can prescribe the test to patients to generate a personalized diet plan, or patients can follow their personalized nutrition guide through the app to improve general well-being and solve their problems. - Main differentiation: Enbiosis is the only clinically proven precision diet technology that claims to address the main cause of chronic disorders. It has conducted three clinical trials and published the results in peer-reviewed journals. Enbiosis's claims are backed by scientific evidence. - The main reason why investors should consider Enbiosis: In recent years, the number of people seeking to address their health problems through alternative methods instead of pharmaceuticals has been increasing. The challenge in alternative medicine is the lack of scientific data. Enbiosis serves as a bridge between alternative medicine and conventional medicine, and there is significant market potential for Enbiosis. For example, Enbiosis has proven the effectiveness of its technology in patients with IBS, who make up about 10% of the population. Offering individuals the opportunity to solve their chronic problems simply by changing their diet within a specific period is something they are interested in and willing to try. - Additionally, investors/distributors can offer a routine follow-up program to check gut health and prevent any kind of diseases, opening the door to long-term recurring revenue. - We have a trade registration certificate to operate.

- Nutraceutical manufacturing, tech marketing & sales company, based in Srebrenik, Bosnia. - Our products are nutraceutical supplements for common disease conditions such as, prostate, hemorrhoids, diabetes and hypertension weight loss and hair loss. - Planning to launch products for more disease conditions such as psoriasis and other skin conditions. - Our clients are individual customers from countries across Eastern Europe such as Serbia, Croatia, Romania etc. Planning to expand to other European countries as well. - We get about 3 to 4k orders every month. Average value of each product is EUR 75. - Manufacturing capacity is 70k products everyday. - Since its inception, the company has showcased significant financial growth, with revenues escalating from €700,000 in 2021 to €5 million last year, and anticipated revenue of around €6 to €7 million for this year. - Till date, we’ve successfully crossed over 45,000 orders, evidencing strong market engagement. - Our seasoned leadership team has been instrumental in nurturing valuable industry relationships. - Our innovative in-house SaaS projects have bolstered our operational prowess: our affiliate network; an ads tracking software; a call center software enhancing our sales processes and a website builder facilitating seamless online presence. - There are 98 permanent employees. Additionally, we have 200+ contract marketing partners. - The company has ISO, GMP, and MoH licenses.

- Well-established massage center in Oslo. - Provide a variety of massages such as: nuad Thai, classic massage, face and scalp massage, medical Thai massage, foot massage and body spa. - High quality clients as it is located in a very posh area in Oslo and is close to the embassy. - We get 2 to 3 clients per day. - Charges are on an hourly basis. Average charges are NOK 900 per hour. - Business has a good expansion by hiring more employees.

Updates on the business: The facility will have growing/extraction/distillation/packaging and R&D lab facilities in order to follow the entire stage of production from mother plants to crystallized forms of stand-alone cannabinoids. The intended R&D lab will be almost 200 sq. m. and will allow us to study lesser-known cannabinoids, and after the start of construction, we are going to sign the 'Partnership Joint Research' program with Athens University. Currently have signed a partnership agreement with a running pharmaceutical company on product supply + joint research program. Later on, we will focus on the distribution channels in each country of presence in order to be prepared to scale to the B2C market with potential own generic medicine and potentially edibles, but that will be decided by the market needs and legislation. We have received an installation license for such end products and as the project progresses we will add new products to the list: - Dried hemp flower > 0.2% THC in the form of teabag (tea bag) for oral consumption; - Hemp oil in drops for oral consumption > 0.2% THC; - Hemp oil for sublingual oral consumption (spray) > 0.2% THC; - Soft cannabis capsules for oral consumption > 0.2% THC; - Capsules with dried hemp blossom > 0.2% THC in powder form for oral consumption. At the moment we have: License and permits; Architectural and engineering plans; Purchase offers from equipment suppliers; All described production processes and laboratories; Long-term land lease for 30+ years with first an option of first to purchase it; Long-term lease and right of build on the neighboring land for the second stage of construction; The entire legal structure of the holding; Verification of processes and architectural solutions under EU GACP & EU GMP standards. By the end of last year have applied for the state subsidy of EUR 3.5mil and have the option to apply for the second state subsidy next year. Additionally, the project has a right for setting fixed corporate tax for the next 12 years. Overall the production facility is projected to grow 6.5+ tons of dried biomaterial (running at 70% capacity) on a single-tier growing table with the ability of scale and potential purchase of third-party biomaterial certified by GACP standards. The EU GMP Laboratory is projected to produce 2+ tons of fine oil with an option of scaling by putting a second processing line. Additionally, the project is built in mind with an option for a second-stage expansion through the building of an additional production site on the neighboring land.

- European company that grows and sells medical cannabis in Europe and to other countries. - We grow medical cannabis in-house in a controlled environment and distribute them to clients. - Growing 74 varieties of medical cannabis in all ranges of THC and CBD. Good opportunity for CBD products, since Europe considers it as a controlled substance. - We used to grow strawberries before and our products were considered the best strawberries in the world that used to sell at EUR 17 per kg. - We stopped growing strawberries and shifted to medical cannabis due to a family member's health reasons. - Business owner and management members have a strong knowledge of agriculture, medicine, Olímpic Sport level medicine, and pharmaceuticals. - Have a stronger demand than before due to Covid-19. - Have 2 running contracts with medical companies and expect 5-6 new contracts in 1-2 months. - Each contract is valid for 2-3 years and could be renewed. - We currently grow 200-300 kgs of medical cannabis and planning to increase the production due to more demand. - Majority of the clients are from Germany and the Netherlands. - Also working with 20 distributors who are allowed to buy and sell medical cannabis. - Have the best equipment and machinery required for the job and the facility including a cloning room, drying room, security facility, and water tanks.

- Business is involved in the agricultural industry. - We produce medical cannabis. - Business produces this cannabis on their own land. - We own a licence for production. - Business was awarded as the most potent autoflower in the world for 28% THC. - We are the highest CBD and THC, cultivators. - Business has a specific variety with up to 20% CBD with CoA. - Company is ready to start operating but due to a lack of funds for marketing and operation, the owner wants to sell the business. - Business has ample potential and opportunity to make profit. - The selling price includes the stocks that we have. - Business is open to get investors as well. - We have attached our pitch deck which we want to present to our buyers/investors.

- Business is dormant at the moment. - Plant extraction facility specializing in the use of solvents, with a focus on hemp. - The primary products are cannabinoid isolates and distillates. - Facility can process up to 600kg of biomass per day with two shifts of 8 hours each, staffed by 12 extraction workers and 2 laboratory personnel. - The equipment includes 3 Gilson CPC 1,000 pro units, which enable the separation and conversion of cannabinoids. Active permits and certifications: 1) Production and processing of controlled substances (THC) authorized by the Chief Pharmaceutical Inspector. 2) ISO 22000 certification - food production safety and management. 3) Sanitary and epidemiological approvals for food and cosmetic production. 4) The newly constructed building has been granted an occupancy permit for the purpose of plant extraction using solvents. 5) Extensive documentation for the entire facility, production processes, quality control, and production safety, including HACCP and ISO compliance. - Highly qualified management team comprising pharmacists, chemists, and university-educated staff. - In-house laboratory equipped with two HPLC machines used for quality control throughout each production stage. The potential for further expansion and obtaining PCA accreditation. Advanced access and security control system, CCTV, designated access areas with fingerprint readers, security guard booth, dedicated data storage server, oxygen level sensors, and fire safety procedures.

- Looking to sell a company owning a 5 acre field in Greece, best suited for medical cannabis cultivation along with the license form Greek government to build the facility. - Greece, with its wide-ranging climate and fertile land, is able to produce agricultural products of the highest quality. - The company at present is not operating and hence not reported any revenue. - The company will be able to produce 2 ton of medical cannabis oil per crop, up to 5 crops per year. - Buyer can monetize by finding clients for the business who are mostly multinational pharmaceutical companies, that prefer 5-year contracts for the whole production and pay up to 3,000 EUR per kg. - Smaller companies in the medical and recreation sectors that buy small quantities (eg 0.5 – 1t) and pay up to 8,000 EUR per kg. - Business does not have any loans and is run by a sole owner.

- Our company is into growing marijuana for medical purposes. - We have an equipped and well-built indoor and outdoor facility that is for the production of dry or wet cannabis flowers. - Currently, we have just done the cultivation for one season which is a process of 6 to 8 months and have a final product stored inside our facility. - The final product is approximately 350 kg, we have not yet sold the products and hence have not reported any revenue. - We have tied-up with a company in Amsterdam that provides us with the seed. - Potential revenue can be generated by selling the final product flower to medical companies, we are not yet tied up with any medical companies. - The business owner is from Albania but due to registration, legal and benefit purposes the business is registered and operating in North Macedonia. - Business does not have any loans and is run by 5 owners. The shareholding pattern is 24:20:20:20.5:15.5. - We have received a valid license from EU regulations for the cultivation and growing of marijuana for medical purposes.